Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2008 4
2009 11
2010 11
2011 6
2012 15
2013 27
2014 28
2015 19
2016 22
2017 13
2018 11
2019 6
2020 2
2021 7
2022 6
2023 5
2024 5
2025 5
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
Management of Menopausal Symptoms: A Review.
Crandall CJ, Mehta JM, Manson JE. Crandall CJ, et al. JAMA. 2023 Feb 7;329(5):405-420. doi: 10.1001/jama.2022.24140. JAMA. 2023. PMID: 36749328 Review.
Oral and transdermal estrogen have similar efficacy. Conjugated equine estrogens (CEE) with or without medroxyprogesterone acetate (MPA) were the only hormonal treatments for which clinical trials were designed to examine cardiovascular events, venous thromboembolis …
Oral and transdermal estrogen have similar efficacy. Conjugated equine estrogens (CEE) with or without medroxyprogesterone ace …
Conjugated oestrogens/bazedoxifene.
[No authors listed] [No authors listed] Aust Prescr. 2017 Jun;40(3):114-115. doi: 10.18773/austprescr.2017.039. Epub 2017 May 10. Aust Prescr. 2017. PMID: 28798519 Free PMC article. Review. No abstract available.
Bazedoxifene-Conjugated Estrogens for Treating Endometriosis.
Flores VA, Stachenfeld NS, Taylor HS. Flores VA, et al. Obstet Gynecol. 2018 Aug;132(2):475-477. doi: 10.1097/AOG.0000000000002739. Obstet Gynecol. 2018. PMID: 29995747
CASE: A patient with stage III endometriosis referred for management of dysmenorrhea and cyclic pelvic pain was treated with 20 mg bazedoxifene and 0.45 mg conjugated estrogens daily for more than 6 months. She noted resolution of pelvic pain. There were no a …
CASE: A patient with stage III endometriosis referred for management of dysmenorrhea and cyclic pelvic pain was treated with 20 mg bazedo …
Bazedoxifene plus conjugated estrogens improve menopausal symptoms in postmenopausal women: a systematic review and meta-analysis.
Bi B, Jiang Y, Shi Y, Ruan F. Bi B, et al. Gynecol Endocrinol. 2022 Oct;38(10):813-821. doi: 10.1080/09513590.2022.2117294. Epub 2022 Aug 28. Gynecol Endocrinol. 2022. PMID: 36036169
Our aim is to evaluate the efficacy of bazedoxifene (BZA) plus conjugated estrogens (CE) on menopausal symptoms in postmenopausal women. ...Furthermore, BZA 20 mg/CE 0.625 mg was more effective than BZA 20 mg/CE 0.45 mg in improving the menopausal symptoms. T …
Our aim is to evaluate the efficacy of bazedoxifene (BZA) plus conjugated estrogens (CE) on menopausal symptoms in post …
Conjugated estrogens and bazedoxifene.
Cada DJ, Baker DE. Cada DJ, et al. Hosp Pharm. 2014 Mar;49(3):273-83. doi: 10.1310/hpj4903-273. Hosp Pharm. 2014. PMID: 24715748 Free PMC article.
Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice.
Genazzani AR, Monteleone P, Giannini A, Simoncini T. Genazzani AR, et al. Hum Reprod Update. 2021 Oct 18;27(6):1115-1150. doi: 10.1093/humupd/dmab026. Hum Reprod Update. 2021. PMID: 34432008 Free article. Clinical Trial.
SEARCH METHODS: A Pubmed search of clinical trials was performed using the following terms: estrogens, progestogens, bazedoxifene, tibolone, selective estrogen receptor modulators, tissue-selective estrogen complex, androgens, and menopause. ...Moreover, a decrease …
SEARCH METHODS: A Pubmed search of clinical trials was performed using the following terms: estrogens, progestogens, bazedoxifene …
Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause.
Morga A, Ajmera M, Gao E, Patterson-Lomba O, Zhao A, Mancuso S, Siddiqui E, Kagan R. Morga A, et al. Menopause. 2024 Jan 1;31(1):68-76. doi: 10.1097/GME.0000000000002281. Epub 2023 Nov 27. Menopause. 2024. PMID: 38016166 Free PMC article.
For 75% responder rates, fezolinetant 45 mg was less effective than tibolone 2.5 mg (not available in the United States) and conjugated estrogens 0.625 mg/bazedoxifene 20 mg (available only as 0.45 mg/20 mg in the United States), did not differ significantly …
For 75% responder rates, fezolinetant 45 mg was less effective than tibolone 2.5 mg (not available in the United States) and conjugated …
Bazedoxifene for HRT?
[No authors listed] [No authors listed] Drug Ther Bull. 2017 Apr;55(4):42-44. doi: 10.1136/dtb.2017.4.0466. Drug Ther Bull. 2017. PMID: 28408389 Review.
Duavive (Pfizer) is a modified-release formulation of conjugated oestrogens plus bazedoxifene acetate (a selective oestrogen receptor modulator). It is licensed for treatment of oestrogen deficiency symptoms in postmenopausal women with a uterus for whom trea …
Duavive (Pfizer) is a modified-release formulation of conjugated oestrogens plus bazedoxifene acetate (a selective oest …
Metabolic and transcriptional effects of bazedoxifene/conjugated estrogens in a model of obesity-associated breast cancer risk.
Giles ED, Cook KL, Jenschke RM, Corleto KA, Landrock D, Mahmood TN, Sanchez KE, Levin A, Hursting SD, Kimler BF, Komm BS, Fabian CJ. Giles ED, et al. JCI Insight. 2025 Mar 6;10(8):e182694. doi: 10.1172/jci.insight.182694. eCollection 2025 Apr 22. JCI Insight. 2025. PMID: 40048260 Free PMC article.
Tamoxifen may also induce or worsen insulin resistance and hypertriglyceridemia, especially in women with obesity. The combination of bazedoxifene and conjugated estrogens (BZA/CE) reduces vasomotor symptoms and is currently undergoing evaluation for breast c …
Tamoxifen may also induce or worsen insulin resistance and hypertriglyceridemia, especially in women with obesity. The combination of baz …
183 results